Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study

Abstract

Background Penile cancer is a relatively rare genital malignancy whose incidence and mortality are rising in many countries. Objective This study aims to assess the recent incidence and mortality patterns and incidence trends of penile cancer. Methods The age-standardized incidence and mortality rates (ASIR and ASMR, respectively) of penile cancer in 2020 were estimated from the Global Cancer Registries (GLOBOCAN) database. Incidence trends of penile cancer from 1973 to 2012 were assessed in 44 populations from 43 countries using the Cancer Incidence in Five Continents plus (CI5plus) and the Nordic Cancer Registries (NORDCAN) databases. Average annual percentage change was calculated to quantify trends in ASIR using joinpoint regression. Results Globally, the estimated ASIR and ASMR of penile cancer were 0.80 (per 100,000) and 0.29 (per 100,000) in 2020, equating to 36,068 new cases and 13,211 deaths in 2020, respectively. There was no significant correlation between the ASIR (P=.05) or ASMR (P=.90) and Human Development Index. In addition, 15 countries saw increasing ASIR for penile cancer, 13 of which were from Europe (United Kingdom, Lithuania, Norway, Estonia, Finland, Sweden, Cyprus, Netherlands, Italy, Croatia, Slovakia, Russia, and the Czech), and 2 from Asia (China and Israel). Conclusions Although the developing countries still bear the higher incidence and mortality of penile cancer, the incidence is on the rise in most European countries. To mitigate the disease burden resulting from penile cancer, measures to lower the risk for penile cancers, including improving penile hygiene and male human papillomavirus vaccination, may be warranted.

The Burden of HPV-Related Hospitalizations: Analysis of Hospital Discharge Records from the Years 2015–2021 from a Southern Italian Region

“…Only the admission rate for penile cancer demonstrated an increasing trend, although it was not significant across the study period. Surely, the incidence of penile cancer is increasing in many countries in recent years [ 25 ] and, despite the lack of significant results, it can heavily impact the healthcare system in the Abruzzo region, and a preventive strategy should be implemented. The results of this study highlight how the greatest decreases in admission rates were reported for genital warts, cervical cancer, and anal cancer.…”

Programmed death‑ligand 1 expression in tumor cells and tumor‑infiltrating lymphocytes are associated with depth of tumor invasion in penile cancer

“…By contrast, in some countries such as India or Brazil, the prevalence is high ranging from 2.3-8.3 per 100,000 person-year ( 2-4 ). In Thailand, according to data from 2008-2012, the age-standardized rate of penile cancer incidence is high (1.4 per 100,000) and ranked top three in the world ( 5 ).…”

Therapeutic Approaches to Penile Cancer: Standards of Care and Recent Developments

“…Penile cancer is an uncommon form of malignancy, with an estimated incidence of 0.8 cases per 100,000 men globally in 2020. 1 It is typically diagnosed in older men, with the majority of cases occurring in men over the age of 60. 2 Squamous cell carcinoma (SCC) is the most common histopathology and is responsible for 95% of all cases.…”